Amino-modified tetraphenylporphyrin compound as well as preparation method and application thereof

A technology of tetraphenylporphyrin and amino modification, which is applied in the field of photosensitive drugs and photodynamic therapy, and can solve the problems of strong dark toxicity of cells

Inactive Publication Date: 2017-11-14
陈志龙
View PDF0 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] Researcher Zhang Danping of our team (Zhang Danping, Design and Synthesis of Photodynamic New Drug Tetrapyrrole Compound, Donghua University Master's Degree Thesis, 2009) passed the 2-nitro-5,10,15,20-tetraphenylporphyrin copper The compound undergoes amino derivative substitution reaction first, and then decoordinates metal copper to synthesize 2-morpholine-5,10,15,20-tetraphenylporphyrin, 2-tetrahydropyrrole-5,10,15,20 -Tetraphenylporphyrin and 2-nitro-3-tetrahydropyrrole-5,10,15,20-tetraphenylporphyrin three compounds; and carried out photodynamic anti-tumor experiment on it, obtained remarkable Anti-tumor effect, but the polarity of these three compounds is small, and the cytotoxicity of dark cells is strong

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Amino-modified tetraphenylporphyrin compound as well as preparation method and application thereof
  • Amino-modified tetraphenylporphyrin compound as well as preparation method and application thereof
  • Amino-modified tetraphenylporphyrin compound as well as preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0034] Preparation of 2-morpholine-5,10,15,20-tetrakis(4-chlorophenyl)porphyrin (photosensitizer 1):

[0035] In a 100mL three-necked flask, 2-nitro-5,10,15,20-tetrakis(4-chlorophenyl)porphyrin (183mg, 0.23mmol) was dissolved in N,N-dimethylformamide (20mL) , adding potassium carbonate (360mg, 2.56mmol) and morpholine (0.2mL), heated to reflux for about 3h, and monitored by TLC until the reaction was complete. The reaction solution was evaporated to dryness, and dichloromethane (150 mL) was added for extraction. The organic phase was washed with water (100 mL×3), washed with saturated brine (100 mL×3), dried over anhydrous sodium sulfate, and filtered. The filtrate was concentrated under reduced pressure, and the resulting residue was subjected to column chromatography (eluent: petroleum ether:dichloromethane=10:1) to obtain a purple solid powder 2-morpholine-5,10,15,20-tetra( 111.4 mg of 4-chlorophenyl) porphyrin, the yield was 58%. 1 H NMR (400MHz, CDCl3): δ8.80-8.68(m, 5...

Embodiment 2

[0037] Preparation of 2-tetrahydropyrrole-5,10,15,20-tetrakis(4-chlorophenyl)porphyrin (photosensitizer 2):

[0038] In a 100mL three-necked flask, 2-nitro-5,10,15,20-tetrakis(4-chlorophenyl)porphyrin (183mg, 0.23mmol) was dissolved in N,N-dimethylformamide (20mL) , adding potassium carbonate (360mg, 2.56mmol) and tetrahydropyrrole (0.2mL), heated to reflux for about 3h, and monitored by TLC until the reaction was complete. The reaction solution was evaporated to dryness, and dichloromethane (150 mL) was added for extraction. The organic phase was washed with water (100 mL×3), washed with saturated brine (100 mL×3), dried over anhydrous sodium sulfate, and filtered. The filtrate was concentrated under reduced pressure, and the resulting residue was subjected to column chromatography (eluent: petroleum ether:dichloromethane=3:1) to obtain a purple solid powder 2-tetrahydropyrrole-5,10,15,20-tetrahydropyrrole (4-Chlorophenyl)porphyrin 90.4 mg, yield 48%. 1 H NMR (400MHz, CDCl...

Embodiment 3

[0040] Preparation of 2-piperidine-5,10,15,20-tetrakis(4-chlorophenyl)porphyrin (photosensitizer 3):

[0041] In a 100mL three-necked flask, 2-nitro-5,10,15,20-tetrakis(4-chlorophenyl)porphyrin (183mg, 0.23mmol) was dissolved in N,N-dimethylformamide (20mL) , adding potassium carbonate (360mg, 2.56mmol) and piperidine (0.3mL), heated to reflux for about 3h, monitored by TLC until the reaction was complete. The reaction solution was evaporated to dryness, and dichloromethane (150 mL) was added for extraction. The organic phase was washed with water (100 mL×3), washed with saturated brine (100 mL×3), dried over anhydrous sodium sulfate, and filtered. The filtrate was concentrated under reduced pressure, and the resulting residue was subjected to column chromatography (eluent: petroleum ether: dichloromethane = 3: 1) to obtain a purple solid powder 2-piperidine-5,10,15,20-tetra( 4-chlorophenyl) porphyrin 88.2 mg, yield 46%. 1 H NMR (400MHz, CDCl 3 ): δ8.83-8.81(m, 3H), 8.76-8...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to an amino-modified tetraphenylporphyrin compound as well as a preparation method and application thereof. The compound has a structure (I) shown in the description, wherein R2 and R3 are positioned at an ortho-position (o-) or meta-position (m-) or para-position (p-) of a benzene ring. The invention relates to the fields of photosensitive medicaments (also known as photosensitizers or photodynamic medicaments) and photodynamic therapy, in particular to a porphyrin photosensitizer, a preparation method thereof and application of the porphyrin photosensitizer in the field of medicine. The photosensitive medicament disclosed by the invention has the advantages of stable chemical property, single component and very strong photodynamic activity, and can be applied to photodynamic therapy of diseases such as tumors, retinal macular degeneration, actinic keratosis, port wine stains and condyloma acuminata.

Description

technical field [0001] The invention relates to the field of photosensitizing drugs and photodynamic therapy, in particular to a class of amino-modified tetraphenylporphyrin compounds and a preparation method and application thereof. Background technique [0002] Photodynamic therapy (PDT) is a new method for the treatment of tumors, macular degeneration, actinic keratosis, port wine stains, genital warts and other diseases. Since entering clinical research in the 1970s, PDT has made remarkable achievements in clinical treatment because of its good selectivity, low toxicity, good reproducibility, safety, minimal invasiveness, synergy and Advantages such as relatively low cost stand out, showing huge potential and strong vitality. [0003] The principle of photodynamic therapy is that after the photosensitizer enters the body, it selectively gathers in the target tissue along with the blood circulation, and then directly irradiates the tumor tissue with a laser of a certain ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07D487/22A61K41/00A61P35/00A61P27/02A61P17/00A61P31/20A61P17/12
CPCA61K41/0071C07D487/22
Inventor 陈志龙廖平永汪新荣张丹萍宋春宏严懿嘉高迎华张向化鲍蕾蕾王来兴韩一平王力胡泰山郑梅珍陈于陈聃烨
Owner 陈志龙
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap